Anne Lenaerts

Dr. Lenaerts is an affiliate with the Department of Microbiology, Immunology and Pathology, involved in Mycobacterial Therapeutics whose laboratory focuses on development and application of novel preclinical animal models to further both anti-tuberculosis drug discovery and assess anti-mycobacterial resistance and latent tuberculosis. Current research projects explore (1) development of new in vitro assays and animal models to accelerate TB drug evaluation, and (2) analysis of various mycobacterial populations with respect to location, pathology and drug responses through use of selective animal models and advanced pathology methods. Dr. Lenaerts interacts closely with Drs. Lyons, Podell, Basaraba, Ordway and Gonzalez-Juarrero, within the CSU MRL.